Oral Nalbuphine in Idiopathic Pulmonary Fibrosis–Associated Cough This randomized clinical trial examines the safety and efficacy of oral nalbuphine in patients with chronic cough caused by idiopathic pulmonary fibrosis.

En pacientes con tos crónica asociada a fibrosis pulmonar idiopática, nalbufina de liberación extendida reduce la frecuencia de tos objetiva y reportada por el paciente a las 6 sem #nalbuphine #IPF #cough jamanetwork.com/journals/jam...

Trevi Therapeutics Shares Promising Findings from Nalbuphine Abuse Liability Study Trevi Therapeutics has unveiled positive results from its recent Human Abuse Potential study on nalbuphine, highlighting its lower 'Drug Liking' compared to traditional opioids.

Trevi Therapeutics Shares Promising Findings from Nalbuphine Abuse Liability Study #United_States #New_Haven #Trevi_Therapeutics #Nalbuphine #Haduvio